The Global Omics Market size is estimated to be valued at USD 100.5 billion in 2025 and is expected to reach USD 218.3 billion by 2032, exhibiting a compound annual growth rate (CAGR) of 11.5% from 2025 to 2032.
The global omics industry is undergoing rapid transformation as integrated multi-omics and AI-driven analytics converge to accelerate discovery. This expert-level analysis offers data-backed market insights and strategic business growth recommendations aligned with evolving industry trends.
Get a Sample Copy of This Report @ https://www.coherentmarketresearch.com/samplepages/135585
Key Takeaways:
Regions
– North America: Robust genomics infrastructure with over 5,200 sequencing centers enabling advanced research pipelines.
– Latin America: Growing investment in proteomics platforms saw 22% growth in Brazil’s research output.
– Europe: Pan-European bioinformatics initiatives drove an 18% rise in multi-omics publications in 2024.
– Asia Pacific: Surge in biotech startups, with China’s genomic service providers expanding by 30% year-on-year.
– Middle East: Government-sponsored metabolomics funding increased 25% in 2024.
– Africa: Collaborative omics research hubs in South Africa boosted local capacities by 15%.
Market Segments:
– Technology: Genomics (NGS used in 68% of research initiatives), Proteomics (mass spectrometry adoption grew 24% in 2024), Metabolomics (high-res MS used in food-safety studies).
– End-user: Pharmaceutical & Biotechnology (driving 55% of pilot multi-omics programs), Academic & Research Institutes (core facility investments rose 18% in Europe in 2024).
Growth Factors:
– Rising Precision Medicine: Global precision medicine market reached USD 120 billion in 2024, propelling omics platform demand by 28%.
– Government Research Funding: US NIH funded genomics initiatives grew 8.5% to USD 7.8 billion in 2024, accelerating technology uptake.
– Technological Advancements: Introduction of AI-enabled multi-omics tools cut data-processing time by 35% in 2024.
– Declining Consumable Costs: Average NGS reagent cost per genome dropped 22% from USD 995 in 2023 to USD 775 in 2024, widening market scope.
– Strategic Collaborations: Over 150 cross-industry alliances in 2024 streamlined integrated omics services, boosting global market dynamics.
Market Trends:
– Multi-omics Integration: Revenue in multi-omics services grew 15% YoY to USD 8.2 billion in 2024, underscoring converged workflows.
– AI & Cloud Analytics: Cloud-based omics analytics subscriptions surged 40% globally in 2024, optimizing data sharing and interpretation.
– Single-Cell Omics Rise: Single-cell sequencing kit shipments hit 310,000 units in 2024, up 32% year-on-year, enabling granular biomarker studies.
– Decentralized Diagnostics: Point-of-care omics assays market revenue hit USD 780 million in 2025, reflecting demand in remote clinical settings.
Get 70% discount on Purchase report @ https://www.coherentmarketinsights.com/promo/buynow/135585
Actionable Insights:
– Production Capacity: USD 1.2 billion worth of NGS sequencers shipped in 2024, with 10,500 units installed globally, fueling supply-side capacity.
– Pricing Trends: Average proteomics instrumentation pricing stabilized at USD 160,000 per unit in 2024, down 4% due to scale economies.
– Exports: Omics consumable exports reached USD 5.4 billion in 2024, led by reagent kits from North America and Europe.
– Imports & Use Cases: Hospital imports of metabolomics assay kits rose 20% in 2024, driven by clinical toxicology applications.
– Nano-scale Indicators: Microfluidic omics chip production expanded 18% in 2024, generating USD 420 million in niche device revenue.
Key Players:
– Thermo Fisher Scientific
– Illumina
– Agilent Technologies
– Bio-Rad Laboratories
– QIAGEN
– Danaher Corporation
– PerkinElmer
– BGI
– Bruker
– Shimadzu Corporation
– Waters Corporation
– Oxford Nanopore Technologies
– Illumina’s strategic partnership with leading academic consortia in 2024 expanded its market share by 4%, reinforcing leadership in genomics sequencing.
– Thermo Fisher’s acquisition of a proteomics startup in mid-2025 integrated novel mass spectrometry solutions, driving a 12% revenue boost in its life sciences segment.
– QIAGEN’s 2024 launch of a cloud-native bioinformatics platform enhanced its competitive positioning, capturing new market opportunities in data-analysis services.
Get 70% discount on Purchase report @ https://www.coherentmarketinsights.com/promo/buynow/135585
FAQs:
- Who are the dominant players in the Omics Market?
Thermo Fisher Scientific, Illumina, Agilent Technologies, Bio-Rad, QIAGEN and Danaher lead market activities, leveraging M&A, partnerships and advanced R&D to maintain top positions.
- What will be the size of the Omics Market in the coming years?
The Omics Market size is projected to grow from USD 100.5 billion in 2025 to USD 218.3 billion by 2032, per our latest forecast.
- Which end-user industry has the largest growth opportunity?
Pharmaceutical & Biotechnology remains the largest growth driver, accounting for over half of pilot multi-omics programs and accelerating market revenue from drug discovery.
- How will Omics Market trends evolve over the next five years?
Key market trends include deeper multi-omics integration, AI-driven analytics, decentralized diagnostics and expansion of single-cell omics applications, reshaping R&D workflows.
- What is the nature of the competitive landscape and challenges in the Omics Market?
Competitive strategies center on M&A, platform diversification and data-analytics enhancements; key challenges include data standardization, regulatory compliance and cost pressures.
- What go-to-market strategies are commonly adopted in the Omics Market?
Players emphasize strategic partnerships, cloud-based service models, pricing flexibility and regional distribution alliances to navigate market dynamics and capture emerging opportunities
About Us:
Coherent Market Insights leads into data and analytics, audience measurement, consumer behaviours, and market trend analysis. From shorter dispatch to in-depth insights, CMI has exceled in offering research, analytics, and consumer-focused shifts for nearly a decade. With cutting-edge syndicated tools and custom-made research services, we empower businesses to move in the direction of growth. We are multifunctional in our work scope and have 450+ seasoned consultants, analysts, and researchers across 26+ industries spread out in 32+ countries.
Contact Us:
Mr. Shah
Senior Client Partner – Business Development
Coherent Market Insights
Phone:
US: + 12524771362
UK: +442039578553
AUS: +61-2-4786-0457
India: +91-848-285-0837
Email: [email protected]




